 |
|
308-nm Excimer Laser for the Treatment of Psoriasis
A Dose-Response Study
Pravit Asawanonda, MD;
R. Rox Anderson, MD;
Yuchiao Chang, PhD;
Charles R. Taylor, MD
Arch Dermatol. 2000;136:619-624.
Objective To determine the dose-response relationship of excimer laser–generated 308-nm UV-B radiation for treating psoriasis.
Design Pilot study with a before-after design.
Setting A university dermatology service.
Patients Thirteen consecutive patients with at least 4 large, stable psoriasis plaques.
Interventions Excimer laser–generated 308-nm UV-B radiation was given to each of 4 plaques, which received 1, 2, 4, and 20 treatments, respectively. Untreated areas within each plaque served as controls. Within each plaque, 8 doses based on multiples of a predetermined minimal erythema dose (MED) were tested in distinct sites. The multiples were 0.5 and 1 (low dose); 2, 3, 4, and 6 (medium dose); and 8 and 16 (high dose). At every treatment, the dose for each site remained fixed at the same MED multiple. A psoriasis severity index score was determined for each area before, every 2 weeks during, and 2 and 4 months after treatment.
Results The mean±SD MED was 203.03±57.84 mJ/cm2. Treatment with high fluences produced significantly better results than that with medium and low fluences at weeks 4, 6, 8, and 10 (P<.05). At 4 months' follow-up, all sites that received low or medium fluences had recurrences, whereas those that underwent a single treatment at 8 and 16 MED multiples remained in remission.
Conclusions With 308-nm UV-B radiation generated by an excimer laser, it is possible to clear psoriasis with as little as 1 treatment with moderately long remission. In contrast to traditional phototherapy techniques, this handheld excimer laser UV-B therapy is selectively directed toward lesional skin, thus sparing the surrounding normal skin from unnecessary radiation exposure. Treatment of other inflammatory diseases and limited psoriasis seems reasonable to pursue with this modality.
From the Departments of Dermatology (Drs Asawanonda, Anderson, and Taylor) and Medicine (Dr Chang), Massachusetts General Hospital, Harvard Medical School, Boston. Dr Asawanonda is now with the Division of Dermatology, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. About 1 year after this study was finished, Dr Anderson became a paid consultant for Laser Phototonics Inc, San Diego, Calif.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2000;136(5):683.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Targeted UV-B Phototherapy for Plaque-type Psoriasis
Asawanonda et al.
Arch Dermatol 2005;141:1542-1546.
ABSTRACT
| FULL TEXT
A Review of the Principles and Use of Lasers in Lower Limb Problems
Cotton
INT J LOW EXTREM WOUNDS 2004;3:133-142.
ABSTRACT
308-nm Excimer Laser for the Treatment of Scalp Psoriasis
Gupta and Taylor
Arch Dermatol 2004;140:518-520.
FULL TEXT
Low-Dose Excimer 308-nm Laser for the Treatment of Oral Lichen Planus
Arch Dermatol 2004;140:415-420.
Energy Delivery Devices for Cutaneous Remodeling: Lasers, Lights, and Radio Waves
Alam et al.
Arch Dermatol 2003;139:1351-1360.
FULL TEXT
308-nm Excimer Laser for the Treatment of Psoriasis: Induration-Based Dosimetry
Taneja et al.
Arch Dermatol 2003;139:759-764.
ABSTRACT
| FULL TEXT
Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser
Baltas et al.
Arch Dermatol 2002;138:1619-1620.
FULL TEXT
Annual Trainee Award for 2000
Orlow
Arch Dermatol 2001;137:948-948.
FULL TEXT
Use of the 308-nm Excimer Laser for Postresurfacing Leukoderma
Friedman and Geronemus
Arch Dermatol 2001;137:824-825.
FULL TEXT
308-nm Excimer Laser Therapy for Psoriasis
Kemeny et al.
Arch Dermatol 2001;137:95-96.
FULL TEXT
Novel Laser Treatment for Psoriasis
Journal Watch Dermatology 2000;2000:2-2.
FULL TEXT
|
